OSE Immunotherapeutics SA (EPA:OSE)
France · Delayed Price · Currency is EUR 3.248
-0.048 (-1.46%)
Jul 14, 2026, 9:05 AM CET
OSE Immunotherapeutics Market Cap
OSE Immunotherapeutics has a market cap or net worth of €77.52 million as of July 13, 2026. Its market cap has decreased by -33.79% in one year.
Market Cap
77.52M
Enterprise Value
91.17M
Revenue
2.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.25
Market Cap Chart
Since March 30, 2015, OSE Immunotherapeutics's market cap has decreased from 104.30M to 77.52M, a decrease of -25.67%. That is a compound annual growth rate of -2.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 77.52M | -32.86% |
| Dec 31, 2025 | 115.47M | -26.37% |
| Dec 31, 2024 | 156.83M | 94.71% |
| Dec 29, 2023 | 80.55M | -34.73% |
| Dec 30, 2022 | 123.40M | -34.26% |
| Dec 31, 2021 | 187.71M | 45.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Valerio Therapeutics Société anonyme | 224.75M |
| Transgene | 207.33M |
| Cellectis | 188.04M |
| Innate Pharma | 147.69M |
| Sensorion | 133.83M |
| Adocia | 73.18M |
| ABIONYX Pharma | 65.36M |
| MaaT Pharma | 52.39M |